Imiquad Cream 0.25 gm belongs to the class of medication called 'immune response modifiers', primarily indicated in the treatment of basal cell carcinoma (a type of skin cancer), actinic keratosis (precancerous growths) and warts on the foreskin of the penis in men and on the vagina in women. Basal cell carcinoma (BCC) is a type of skin cancer where that appears as a slightly transparent bump on the upper layer of skin. Actinic keratosis is a scaly, rough patch on the skin that develops due to excessive sun exposure for many years. A wart is a small, fleshy bump on the skin or mucous membrane. Warts can spread from one body part to another.
Imiquad Cream 0.25 gm consists of 'Imiquimod', which works by stimulating the immune system of the body so that the immune system releases chemicals that fights various virus and destroy the cells of cancer. When Imiquad Cream 0.25 gm is used directly on precancerous lesions and skin cancers, then it causes inflammation on the affected part of the skin that destroys the lesion. However, the degree of infection varies from person to person.
Imiquad Cream 0.25 gm is for external (skin) use only. You should use this medicine exactly as prescribed by your doctor. Imiquad Cream 0.25 gm may cause side effects such as wearing away of the upper layers of the skin, irritation, redness, itching and burning sensation at the application site. These side effects are usually mild and temporary. However, if any of these side effects persist or get worse, consult a doctor immediately.
Do not use Imiquad Cream 0.25 gm if you are allergic to any contents of it. It is not recommended to use Imiquad Cream 0.25 gm on broken or bleeding skin and warts more than 4 centimeters in size (approximately the size of a postal stamp). Imiquad Cream 0.25 gm is not recommended for pregnant women, breastfeeding mothers and children below 12 years of age. Imiquad Cream 0.25 gm may not interact with alcohol. Imiquad Cream 0.25 gm may not affect your ability to drive.